SCHEMBL4818666

SCHEMBL4818666

CN(CCC[C@@H]1CO1)C(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
ASGR1 P07306 1/20 0.35
METAP2 P50579 1/20 0.33
CA14 Q9ULX7 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
FPR3 P25089 1/20 0.32
FPR2 P25090 1/20 0.32
CPB2 Q96IY4 4/20 0.32
CTSK P43235 2/20 0.31
CTSD P07339 1/20 0.31
CTSL P07711 1/20 0.31
CTSB P07858 1/20 0.31
CTSS P25774 1/20 0.31
PDK2 Q15119 1/20 0.31
TRPV4 Q9HBA0 1/20 0.31
NFKB1 P19838 1/20 0.30
NFKB2 Q00653 1/20 0.30
RELA Q04206 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4810634 1.00 ALDH1A1 (0.38) ALDH1A1ASGR1METAP2CA14HDAC1
SCHEMBL4810639 1.00 ALDH1A1 (0.38) ALDH1A1ASGR1METAP2CA14HDAC1
SCHEMBL1022363 0.80 ALDH1A1 (0.38) ALDH1A1ASGR1HDAC1HDAC2HDAC6
SCHEMBL1022362 0.80 ALDH1A1 (0.38) ALDH1A1ASGR1HDAC1HDAC2HDAC6
SCHEMBL16854675 0.80 ASGR1 (0.34) ALDH1A1ASGR1METAP2FPR3FPR2
SCHEMBL16854645 0.80 ASGR1 (0.34) ALDH1A1ASGR1METAP2FPR3FPR2
SCHEMBL5546669 0.76 HDAC6 (0.38) METAP2CA14HDAC1HDAC2HDAC6
SCHEMBL27123113 0.76 ITGB3 (0.37)
SCHEMBL10260946 0.75 HDAC6 (0.40) ASGR1CA14HDAC1HDAC2HDAC6
SCHEMBL13650556 0.75 ALDH1A1 (0.37) ALDH1A1METAP2FPR3FPR2CPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365174-B2 Azalide and azalactam derivatives and method for producing the same MEIJI SEIKA KAISHA, LTD. (JP) 2008-04-29 US disclosed
US-20070042974-A1 Nozel azalide and azalactam derivatives and method for producing the same MEIJI SEIKA KAISHA, LTD. (JP) 2007-02-22 US disclosed
EP-1661904-A1 NOVEL AZALIDE AND AZALACTAM DERIVATIVES AND PROCESS FOR THE PRODUCTION OF THE SAME MEIJI SEIKA KAISHA LTD. (JP) 2006-05-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070042974-A1 Nozel azalide and azalactam derivatives and method for producing the same BCL6, NR4A1, NR4A2 ALDH1A1 1363/4885ASGR1 243/4885METAP2 3920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.